New counseling approach aims to boost HIV prevention in young black men who have sex with men

NCT ID NCT05087680

First seen Jul 01, 2026 · Last updated Jul 01, 2026

Summary

This study tests a counseling program called ACTPrEP, designed to help young Black men who have sex with men (ages 18-34) start and continue taking PrEP, a daily pill that prevents HIV. The program uses acceptance and commitment therapy to address thoughts and feelings that might get in the way of using PrEP. Participants are randomly assigned to either the ACTPrEP program or a standard PrEP education session, and researchers measure how many people stay in the study and how satisfied they are with the program.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Acceptance and Commitment Therapy (ACT)-based counseling program

What this could lead to

If successful, this counseling approach could help more young Black men who have sex with men consistently use PrEP, reducing HIV transmission in a high-risk group.

What could go wrong

This is a small, early-stage feasibility study, so results may not apply broadly. The intervention may not improve PrEP use more than standard education.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Univeristy of Mississippi Medical Center

    Jackson, Mississippi, 39216, United States